SC 13D
SCHEDULE 13D FOR ESPERION THERAPEUTICS, INC.
- Company
- Esperion Therapeutics, Inc.
- Filed
- October 30, 2014
- Accession Number
- 0000904454-14-000727
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →